General Information of Drug (ID: DMNKV3O)

Drug Name
XEN007 Drug Info
Indication
Disease Entry ICD 11 Status REF
Migraine 8A80 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMNKV3O
VARIDT Drug ID
DR01044

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flunarizine DMZU5JP Migraine 8A80 Approved [1]
TH-9229 DMG1MPD Reperfusion injury ND56.Z Terminated [2]
CPU-228 DMM8FUT Cardiac failure BD10-BD13 Investigative [3]
omega-conotoxin GVIA DM4BQFW Discovery agent N.A. Investigative [4]
Alpha-eudesmol DMYSCQU Discovery agent N.A. Investigative [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated calcium channel alpha Cav2.1 (CACNA1A) TTX4QDJ CAC1A_HUMAN Inhibitor [1]

References

1 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008159)
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 532).
4 Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem. 2000 Nov 10;275(45):35335-44.
5 Alpha-eudesmol, a P/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res. 2000 Aug 4;873(1):94-101.